Deutsche Bank’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,196
Closed -$1.02M 4829
2021
Q2
$1.02M Sell
6,196
-112,400
-95% -$18.8M ﹤0.01% 2752
2021
Q1
$18.2M Buy
118,596
+109,812
+1,250% +$14.9M 0.01% 933
2020
Q4
$1.1M Sell
8,784
-372
-4% -$41.6K ﹤0.01% 2374
2020
Q3
$929K Sell
9,156
-112,425
-92% -$11.5M ﹤0.01% 2244
2020
Q2
$11.8M Buy
121,581
+29,155
+32% +$2.71M 0.01% 903
2020
Q1
$7.67M Buy
92,426
+21,189
+30% +$2.07M 0.01% 1026
2019
Q4
$7.92M Sell
71,237
-38,774
-35% -$3.99M 0.01% 1208
2019
Q3
$10.9M Buy
110,011
+28,063
+34% +$2.79M 0.01% 1035
2019
Q2
$8.12M Sell
81,948
-5,917
-7% -$565K ﹤0.01% 1502
2019
Q1
$9.69M Buy
87,865
+49,056
+126% +$5.13M 0.01% 1397
2018
Q4
$3.57M Sell
38,809
-79,729
-67% -$8.07M ﹤0.01% 2020
2018
Q3
$13.1M Sell
118,538
-2,158
-2% -$225K 0.01% 1423
2018
Q2
$11.3M Buy
120,696
+15,862
+15% +$1.37M 0.01% 1643
2018
Q1
$8.7M Sell
104,834
-20,378
-16% -$1.81M ﹤0.01% 1740
2017
Q4
$11.4M Sell
125,212
-177,722
-59% -$14.8M 0.01% 1394
2017
Q3
$23.1M Buy
302,934
+18,082
+6% +$1.37M 0.02% 939
2017
Q2
$21.4M Sell
284,852
-19,546
-6% -$1.35M 0.02% 908
2017
Q1
$19.9M Buy
304,398
+109,897
+57% +$6.47M 0.01% 882
2016
Q4
$10.7M Sell
194,501
-38,765
-17% -$2.13M 0.01% 1210
2016
Q3
$13.2M Sell
233,266
-96,028
-29% -$4.71M 0.01% 1118
2016
Q2
$13.7M Buy
329,294
+296,804
+914% +$13.7M 0.01% 1109
2016
Q1
$1.39M Buy
32,490
+14,793
+84% +$625K ﹤0.01% 2598
2015
Q4
$799K Sell
17,697
-18,687
-51% -$785K ﹤0.01% 3026
2015
Q3
$1.41M Buy
36,384
+25,564
+236% +$1.02M ﹤0.01% 2717
2015
Q2
$392K Buy
10,820
+1,917
+22% +$60.6K ﹤0.01% 3531
2015
Q1
$255K Sell
8,903
-85,389
-91% -$2.38M ﹤0.01% 3669
2014
Q4
$2.28M Buy
+94,292
New +$2.13M ﹤0.01% 2574

Other funds holding PRAH

Deutsche Bank's PRAH Position: Q3 2021 in Review

Deutsche Bank sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 6,196 shares — an estimated $1.02M sold.

Deutsche Bank first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $23.1M in Q3 2017. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Deutsche Bank reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Deutsche Bank sold 6,196 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.02M.
  • Deutsche Bank first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
  • Deutsche Bank's PRA Health Sciences, Inc. position peaked at $23.1M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.